Olink

Olink®
Part of Thermo Fisher Scientific

Splenectomy induces biochemical remission and regeneration in experimental murine autoimmune hepatitis

European Journal of Medical Research, 2022

Dywicki J., Buitrago-Molina L., Noyan F., Schlue J., Iordanidis K., Manns M., Wedemeyer H., Jaeckel E., Hardtke-Wolenski M.

Disease areaApplication areaSample typeProducts
Immunological & Inflammatory Diseases
Pathophysiology
Serum
Olink Target 96 Mouse

Olink Target 96 Mouse

Abstract

Autoimmune hepatitis (AIH) is a chronic immune-mediated inflammatory liver disease. It is known that AIH originates not from the spleen but from the liver itself. Nonetheless, most details of the etiology and pathophysiology are unknown. We induced experimental murine AIH (emAIH) in NOD/Ltj mice by single administration of a replication-deficient adenovirus and performed splenectomy during late-stage disease. Biochemical disease remission occurred, which was characterized by improvement in transaminase levels. The causes of this remission included a shift in the transcriptomic signature of serum proteins toward regeneration. At the cellular level, there was a marked decrease in activated CD8+T cells and an increase in intrahepatic regulatory T cells (Tregs). Here, intrahepatic Treg numbers correlated with biochemical remission. Notably, an imbalance in the T-cell/B-cell ratio was observed, with a disproportionate increase in total B cells. In summary, intrahepatic increases in Tregs, biochemical remission, and regeneration could be induced by splenectomy in the late stage of emAIH.

Read publication ↗